New Tool Better Estimates CV Risk in People With Lupus
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.
Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.
Serial NT-proBNP assays could potentially identify which of those without clinical disease might most benefit from heart-failure preventive therapies, researchers propose.
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.
The modeling study shows "clinically meaningful" gains in survival and lower costs with NGS over single-gene testing in metastatic nonsquamous NSCLC.
Ayahuasca's action on serum brain-derived neurotrophic factor and serum cortisol is associated with clinical improvements in patients with major depressive disorder.